Sopharma AD notifies that for January 2016 the Company recorded an increase of sales revenues of 40% compared to the same month of 2015, including 2% increase in domestic sales and 99% increase in export sales. The increase in export sales is due to the low baseline from 2015, when due to the volatility of the Russian ruble the sales on the Russian market were temporarily stopped.

Sopharma AD issued this content on 04 February 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 12 February 2016 16:02:20 UTC